カテゴリー： GlobalInfoResearch, 世界

乾癬性関節炎（PsA）治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Psoriatic Arthritis (PsA) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9103337）・商品コード：GIR9103337
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月26日（※2024年版があります。お問い合わせください）
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、乾癬性関節炎（PsA）治療の世界市場について調べ、まとめました。種類別セグメントは、非ステロイド系抗炎症薬、疾患修飾性抗リウマチ薬、生物製剤等、用途別セグメントは、病院、診療所、その他等に区分しました。乾癬性関節炎（PsA）治療の世界市場概観、企業動向、企業別乾癬性関節炎（PsA）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・乾癬性関節炎（PsA）治療の市場概観
・乾癬性関節炎（PsA）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・乾癬性関節炎（PsA）治療の企業別販売動向、市場シェア、市場集中度、競争動向
・乾癬性関節炎（PsA）治療の世界市場規模
・乾癬性関節炎（PsA）治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・乾癬性関節炎（PsA）治療のアメリカ市場規模推移
・乾癬性関節炎（PsA）治療のカナダ市場規模推移
・乾癬性関節炎（PsA）治療のメキシコ市場規模推移
・乾癬性関節炎（PsA）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・乾癬性関節炎（PsA）治療のドイツ市場規模推移
・乾癬性関節炎（PsA）治療のイギリス市場規模推移
・乾癬性関節炎（PsA）治療のロシア市場規模推移
・乾癬性関節炎（PsA）治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・乾癬性関節炎（PsA）治療の日本市場規模推移
・乾癬性関節炎（PsA）治療の中国市場規模推移
・乾癬性関節炎（PsA）治療の韓国市場規模推移
・乾癬性関節炎（PsA）治療のインド市場規模推移
・乾癬性関節炎（PsA）治療の東南アジア市場規模推移
・乾癬性関節炎（PsA）治療の南米市場分析（ブラジル、アルゼンチン等）
・乾癬性関節炎（PsA）治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・乾癬性関節炎（PsA）治療の種類別分析/販売量、売上、市場シェア（非ステロイド系抗炎症薬、疾患修飾性抗リウマチ薬、生物製剤）
・乾癬性関節炎（PsA）治療の用途別分析/市場規模（病院、診療所、その他）
・乾癬性関節炎（PsA）治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・乾癬性関節炎（PsA）治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global Psoriatic Arthritis (PsA) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Psoriatic Arthritis (PsA) Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Psoriatic Arthritis (PsA) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Psoriatic Arthritis (PsA) Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Johnson & Johnson
AbbVie
Novartis
UCB
Roche
Bristol-Myers Squibb
Eli Lilly
Amgen
AstraZeneca
Celgene

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Nonsteriodal Anti-inflammatory Drugs
Disease Modifying Antirheumatic Drugs
Biologics

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

1 Psoriatic Arthritis (PsA) Treatment Market Overview
1.1 Product Overview and Scope of Psoriatic Arthritis (PsA) Treatment
1.2 Classification of Psoriatic Arthritis (PsA) Treatment by Types
1.2.1 Global Psoriatic Arthritis (PsA) Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Types in 2018
1.2.3 Nonsteriodal Anti-inflammatory Drugs
1.2.4 Disease Modifying Antirheumatic Drugs
1.2.5 Biologics
1.3 Global Psoriatic Arthritis (PsA) Treatment Market by Application
1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Psoriatic Arthritis (PsA) Treatment Market by Regions
1.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Psoriatic Arthritis (PsA) Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Psoriatic Arthritis (PsA) Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Psoriatic Arthritis (PsA) Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Psoriatic Arthritis (PsA) Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Psoriatic Arthritis (PsA) Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Psoriatic Arthritis (PsA) Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 UCB
2.5.1 Business Overview
2.5.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Roche
2.6.1 Business Overview
2.6.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Amgen
2.9.1 Business Overview
2.9.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Celgene
2.11.1 Business Overview
2.11.2 Psoriatic Arthritis (PsA) Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Psoriatic Arthritis (PsA) Treatment Market Competition, by Players
3.1 Global Psoriatic Arthritis (PsA) Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Psoriatic Arthritis (PsA) Treatment Players Market Share
3.2.2 Top 10 Psoriatic Arthritis (PsA) Treatment Players Market Share
3.3 Market Competition Trend
4 Global Psoriatic Arthritis (PsA) Treatment Market Size by Regions
4.1 Global Psoriatic Arthritis (PsA) Treatment Revenue and Market Share by Regions
4.2 North America Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
5 North America Psoriatic Arthritis (PsA) Treatment Revenue by Countries
5.1 North America Psoriatic Arthritis (PsA) Treatment Revenue by Countries (2014-2019)
5.2 USA Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
6 Europe Psoriatic Arthritis (PsA) Treatment Revenue by Countries
6.1 Europe Psoriatic Arthritis (PsA) Treatment Revenue by Countries (2014-2019)
6.2 Germany Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
6.4 France Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Countries
7.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Countries (2014-2019)
7.2 China Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
7.5 India Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
8 South America Psoriatic Arthritis (PsA) Treatment Revenue by Countries
8.1 South America Psoriatic Arthritis (PsA) Treatment Revenue by Countries (2014-2019)
8.2 Brazil Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Psoriatic Arthritis (PsA) Treatment by Countries
9.1 Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
10 Global Psoriatic Arthritis (PsA) Treatment Market Segment by Type
10.1 Global Psoriatic Arthritis (PsA) Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Type (2019-2024)
10.3 Nonsteriodal Anti-inflammatory Drugs Revenue Growth Rate (2014-2024)
10.4 Disease Modifying Antirheumatic Drugs Revenue Growth Rate (2014-2024)
10.5 Biologics Revenue Growth Rate (2014-2024)
11 Global Psoriatic Arthritis (PsA) Treatment Market Segment by Application
11.1 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2014-2019)
11.2 Psoriatic Arthritis (PsA) Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast (2019-2024)
12.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast (2019-2024)
12.2 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Regions (2019-2024)
12.3 North America Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
12.6 South America Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Psoriatic Arthritis (PsA) Treatment Picture
Table Product Specifications of Psoriatic Arthritis (PsA) Treatment
Table Global Psoriatic Arthritis (PsA) Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Types in 2018
Figure Nonsteriodal Anti-inflammatory Drugs Picture
Figure Disease Modifying Antirheumatic Drugs Picture
Figure Biologics Picture
Table Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) by Application (2014-2024)
Figure Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Psoriatic Arthritis (PsA) Treatment Type and Applications
Table AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Psoriatic Arthritis (PsA) Treatment Type and Applications
Table UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Psoriatic Arthritis (PsA) Treatment Type and Applications
Table AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Psoriatic Arthritis (PsA) Treatment Type and Applications
Table Celgene Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Players (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Players in 2017
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Psoriatic Arthritis (PsA) Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Psoriatic Arthritis (PsA) Treatment Revenue Market Share in 2018
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Regions in 2018
Figure North America Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure South America Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Table North America Psoriatic Arthritis (PsA) Treatment Revenue by Countries (2014-2019)
Table North America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries in 2018
Figure USA Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Table Europe Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries in 2018
Figure Germany Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure UK Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure France Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries in 2018
Figure China Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure India Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Table South America Psoriatic Arthritis (PsA) Treatment Revenue by Countries (2014-2019)
Table South America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries in 2018
Figure Brazil Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2014-2019)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Type (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Type (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Type in 2019
Table Global Psoriatic Arthritis (PsA) Treatment Revenue Forecast by Type (2019-2024)
Figure Global Psoriatic Arthritis (PsA) Treatment Market Share Forecast by Type (2019-2024)
Figure Global Nonsteriodal Anti-inflammatory Drugs Revenue Growth Rate (2014-2019)
Figure Global Disease Modifying Antirheumatic Drugs Revenue Growth Rate (2014-2019)
Figure Global Biologics Revenue Growth Rate (2014-2019)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue by Application (2014-2019)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Application (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Application (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Application in 2019
Table Global Psoriatic Arthritis (PsA) Treatment Revenue Forecast by Application (2019-2024)
Figure Global Psoriatic Arthritis (PsA) Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
Figure Europe Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
Figure South America Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue Market Forecast (2019-2024)


【掲載企業】

Pfizer、Johnson & Johnson、AbbVie、Novartis、UCB、Roche、Bristol-Myers Squibb、Eli Lilly、Amgen、AstraZeneca、Celgene、

★調査レポート[乾癬性関節炎（PsA）治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9103337)販売に関する免責事項を必ずご確認ください。
★調査レポート[乾癬性関節炎（PsA）治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 糖尿病性足潰瘍（DFU）治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103204 / GlobalInfoResearch / 2019年9月25日 / 本調査レポートは、糖尿病性足潰瘍（DFU）治療の世界市場について調べ、まとめました。種類別セグメントは、創傷ケアドレッシング、生物製剤、治療機器、抗生物質治療、その他等、用途別セグメントは、神経障害性潰瘍、虚血性潰瘍、神経虚血性潰瘍等に区分しました。糖尿病性足潰瘍（DFU）治療の世界市場概観、企業動向、企業別糖尿病性足潰瘍（DFU）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・糖尿病性足潰瘍（DFU）治療の市場概観 ・糖尿病性足潰瘍（DFU）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・糖尿病性足潰瘍（DFU）治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・糖尿病性足潰瘍（DFU）治療の世界市場規模 ・糖尿病性足潰瘍（DFU）治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・糖尿病性足潰瘍（DFU）治療のアメリカ市場規模推移 ・糖尿病性足潰瘍（DFU）治療のカナダ市場規模推移 ・糖尿病性足潰瘍（DFU）治療のメキシコ市場規模推移 ・糖尿病性足潰瘍（DFU）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Scope of the Report: The global Diabetic Foot Ulcer (DFU) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United...
  • 顧みられない熱帯病（NTD）治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102035 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、顧みられない熱帯病（NTD）治療の世界市場について調べ、まとめました。種類別セグメントは、従来法、分子/現代法等、用途別セグメントは、臨床検査室、病院/診療所、在宅医療等に区分しました。顧みられない熱帯病（NTD）治療の世界市場概観、企業動向、企業別顧みられない熱帯病（NTD）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・顧みられない熱帯病（NTD）治療の市場概観 ・顧みられない熱帯病（NTD）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・顧みられない熱帯病（NTD）治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・顧みられない熱帯病（NTD）治療の世界市場規模 ・顧みられない熱帯病（NTD）治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・顧みられない熱帯病（NTD）治療のアメリカ市場規模推移 ・顧みられない熱帯病（NTD）治療のカナダ市場規模推移 ・顧みられない熱帯病（NTD）治療のメキシコ市場規模推移 ・顧みられない熱帯病（NTD）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Tropical diseases are diseases that are prevalent in or unique to tropical and subtropical regions. The diseases are less prevalent in temperate climates, due in part to the occurrence of a cold season, which controls the insect population by forcing hibernation. Scope of the Report: The global Neglected Tropical Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing...

    • ◆H&Iグローバルリサーチのお客様（例）◆